Guizhi Zhu
Virginia Commonwealth University
H-index: 63
North America-United States
Top articles of Guizhi Zhu
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Engineering cGAS-agonistic oligonucleotides as therapeutics for cancer immunotherapy | Molecular Therapy-Nucleic Acids | Shurong Zhou Ting Su Furong Cheng Janet Cole Xiang Liu | 2024/3/12 |
Single-dose injectable nanovaccine-in-hydrogel for robust immunotherapy of large tumors with abscopal effect | Science advances | Furong Cheng Ting Su Shurong Zhou Xiang Liu Suling Yang | 2023/7/14 |
Nucleic acid immunotherapeutics and vaccines: a promising approach to glioblastoma multiforme treatment | Lauren Dain Guizhi Zhu | 2023/5/10 | |
Molecular and nanoscale engineering of nucleic acid theranostics and vaccines | Frontiers in Bioengineering and Biotechnology | Xiaohong Tan Zilong Zhao Ruowen Wang Guizhi Zhu | 2023/1/5 |
Engineering and delivery of cGAS-STING immunomodulators for the immunotherapy of cancer and autoimmune diseases | Shurong Zhou Furong Cheng Yu Zhang Ting Su Guizhi Zhu | 2023/10/6 | |
Lymph node-targeting adjuvant/neoantigen-codelivering vaccines for combination glioblastoma radioimmunotherapy | Theranostics | Ting Su Shurong Zhou Suling Yang Nicholas Humble Fuwu Zhang | 2023 |
Targeting Lymph Nodes for Systemic Immunosuppression Using Cell‐Free‐DNA‐Scavenging And cGAS‐Inhibiting Nanomedicine‐In‐Hydrogel for Rheumatoid Arthritis Immunotherapy | Advanced Science | Furong Cheng Ting Su Yangtengyu Liu Shurong Zhou Jialong Qi | 2023/9 |
Ionizable polymeric nanocarriers for the codelivery of bi-adjuvant and neoantigens in combination tumor immunotherapy | Bioactive Materials | Ting Su Xiang Liu Shuibin Lin Furong Cheng Guizhi Zhu | 2023/8/1 |
Responsive multivesicular polymeric nanovaccines that codeliver STING agonists and neoantigens for combination tumor immunotherapy | Advanced science | Ting Su Furong Cheng Jialong Qi Yu Zhang Shurong Zhou | 2022/8 |
Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines | Xiang Liu Yu Zhang Shurong Zhou Lauren Dain Lei Mei | 2022/8/1 | |
Pulmonary delivery of mucosal nanovaccines | Wei Tang Yu Zhang Guizhi Zhu | 2022 | |
Single-stranded circular DNA theranostics | Tingting Shen Yu Zhang Lei Mei Xiao-Bing Zhang Guizhi Zhu | 2022 | |
Intergenomic and epistatic interactions control free radical mediated pancreatic β-cell damage | Frontiers in Genetics | Jing Chen Renhua Li Robert L Whitener Edward H Leiter Clayton E Mathews | 2022/10/7 |
STING pathway and modulation for cancer immunotherapy | Ting Su Nadia Tasnim Ahmed Shurong Zhou Xiang Liu Guizhi Zhu | 2022/1/1 | |
Polymeric micelles amplify tumor oxidative stresses through combining PDT and glutathione depletion for synergistic cancer chemotherapy | Chemical Engineering Journal | Ting Su Furong Cheng Yuji Pu Jun Cao Shuibin Lin | 2021/5/1 |
ExoHCR: a sensitive assay to profile PD-L1 level on tumor exosomes for immunotherapeutic prognosis | Biophysics reports | Lujun Hu Wenjie Chen Shurong Zhou Guizhi Zhu | 2020/12 |
Delivery of nucleic acid therapeutics for cancer immunotherapy | Shurong Zhou Wenjie Chen Janet Cole Guizhi Zhu | 2020/6/1 | |
A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer | Science advances | Qianqian Ni Fuwu Zhang Yijing Liu Zhantong Wang Guocan Yu | 2020/3/18 |
Nucleic acid immunotherapeutics for cancer | Tingting Shen Yu Zhang Shurong Zhou Shuibin Lin Xiao-Bing Zhang | 2020/3/16 | |
pH‐Responsive STING‐Activating DNA Nanovaccines for Cancer Immunotherapy | Advanced therapeutics | Yu Zhang Tingting Shen Shurong Zhou Weinan Wang Shuibin Lin | 2020/9 |
Co-Authors
